The digital pathology market is driven by increased teleconsultations, increased usage of digital pathology to improve lab efficiency, and its application in drug discovery and companion diagnostics.
AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has acquired PathXL, a Northern Ireland-based leader in digital pathology image analysis, workflow software and ...
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application ...
Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced multiple U.S. Food and Drug Administration (FDA) 510 (k) clearances that ...
TUCSON, Ariz., Oct. 26, 2023 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today collaborations with Ibex Medical Analytics and Amazon Web Services, enabling pathology laboratories to ...
The vision for automated diagnosis of computer-analyzed biopsy images is one that has the potential to drive enormous advances in pathology. The idea of being able to have a computer supplement the ...
Proscia, a health IT startup that developed a platform for digital pathology software aimed at clinicians and researchers to make the process of sharing and storing data easier to support cancer ...
PathPresenter, a pioneer in the development of digital pathology software, and 4D Path Inc., developer of a pan-cancer diagnostic and precision oncology platform enabling AI-based biomarker typing and ...
Digital pathology software developer Inspirata has secured an FDA clearance for its tissue slide analysis program that can be used with multiple scanners. This allows pathologists using the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results